Bookmark and Share

Supplying the newest API's & rarest Molecules for your R&D needsSupplying the newest API's & rarest Molecules for your R&D needs
  Home Products Company Profile Compounding APIs Events Resources Blog Contact Us
 
 

Featured Products

LGM Pharma is proud to present to you our new line of Monoclonal Antibodies (mAbs).

Monoclonal Antibody therapy has been proven effective in treating life threatening diseases such as cancer. Monoclonal Antibodies (mAbs) are being used earlier in the course of diseases with much success. This has sparked incredible growth in the manufacturing and supply of new mAbs, and has provided much promising news for many cancer patients.

Currently LGM Pharma supplies these cutting edge mAbs for cancer research. The following sample quantities are available for your R&D purposes:

Product Name: CAS#: CATEGORY: AVAILABILITY:
Abciximab 143653-53-6 Antithrombotic Sample Quantities
Abagovomab 792921-10-9 Antineoplastic Sample Quantities
Bavituximab 648904-28-3 New Molecule Sample Quantities
Cetuximab 205923-56-4 Antineoplastic Sample Quantities
Lexatumumab 845816-02-6 New Molecule Sample Quantities
Motavizumab 677010-34-3 New Molecule Sample Quantities
Ofatumumab 679818-59-8, 769818-59-8 New Molecule Sample Quantities
Panitumumab 339177-26-3 New Molecule Sample Quantities
Rituximab 174722-31-7 New Molecule Sample Quantities
Trastuzumab 180288-69-1 Antineoplastic Sample Quantities

Products Coming Soon

Currently, LGM Pharma has several new mAbs under development. Lab samples of the following mAbs will soon be available:

Sample Quantities: Product Name: CAS#:
Coming Soon Adalimumab 331731-18-1
Coming Soon Alemtuzumab 216503-57-0
Coming SoonBasiliximab 179045-86-4
Coming Soon Bevacizumab 216974-75-3
Coming SoonDaclizumab 152923-56-3
Coming SoonGemtuzumab 220578-59-6
Coming Soon Infliximab 170277-31-3
Coming SoonNimotuzumab 780758-10-3
Coming SoonPalivizumab 188039-54-5

All of our products are available for prompt delivery. Inquiries for DMF, cGMP and all pack sizes welcome.

Call our customer support number (561) 981-9994, or contact us online at any time.


Disclaimer: Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

   

Recent Blog Posts

Monoclonal Antibodies (mAb's) – Growth, Supply, and Uses for Cancer Treatment
Posted on: 2/11/11

What is a monoclonal antibody? A monoclonal antibody is a laboratory-produced molecule that's carefully engineered to attach to specific defects in your cancer cells. Monoclonal antibodies mimic the antibodies...
More >


Dutasteride – FDA Denies Specific Use, But Does Not Affect Existing Approval
Posted on: 1/27/11

On Wednesday January 26, 2011, GlaxoSmithKline (GSK) announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA)....
More >


Plerixafor – Primary Usage, Stem Cells, and Availability for R&D Purposes
Posted on: 1/19/11

Plerixafor is a new compound that can be used as an effective drug to cure cancer patients. This drug is an immunostimulant and is used to increase hematopoietic stem cells in patients suffering from cancer...
More >


Peramivir – one of the most effective treatments for H1N1 Swine Flu patients
Posted on: 1/10/11

Peramivir is one of the most effective drugs that can be used to treat patients suffering from swine flu. During the H1N1 influenza epidemic crisis in 2009, the US Food and Drug Administration (FDA)...
More >
 
 
6400 Congress Ave., Suite 1400, Boca Raton FL 33487 • Phone: (561) 981-9994 • Fax: (561) 892-0580 • Sitemap
Copyright © 2011 LGM Pharma, LLC. All Rights Reserved | Privacy Policy